Invention Grant
- Patent Title: Compositions and methods for producing dendritic cells
-
Application No.: US15275073Application Date: 2016-09-23
-
Publication No.: US10765727B2Publication Date: 2020-09-08
- Inventor: Bruce W. Lyday , Tony Chen
- Applicant: PrimeVax Immuno-Oncology, Inc.
- Applicant Address: US CA Orange
- Assignee: Primevax Immuno-Oncology, Inc.
- Current Assignee: Primevax Immuno-Oncology, Inc.
- Current Assignee Address: US CA Orange
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K39/00
- IPC: A61K39/00 ; C12N5/0784 ; A61K39/12 ; A61K35/768 ; C12N7/00 ; A61K39/39

Abstract:
Described herein are compositions and methods for treating a disease, particularly a cancer, with primed dendritic cells recognizing a tumor antigen. The methods may comprise storing, shipping and/or culturing dendritic cells, where the dendritic cells are stored on a hard surface. Lysis protocols are described where the lysis does not result in complete lysis of cells in order to provide cell surface molecules maintained in a cell surface-embedded state. Non-lethal Dengue virus strains are also provided for therapeutic purposes.
Public/Granted literature
- US20170087233A1 COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS Public/Granted day:2017-03-30
Information query